Microencapsulation experts are professionals dedicated to the design and development of microscopic capsules that protect and deliver active pharmaceutical ingredients (APIs) in a controlled manner. Their expertise lies in selecting suitable coating materials—such as biodegradable polymers, lipids, or polysaccharides—and employing various encapsulation techniques including spray drying, coacervation, and solvent evaporation. These microcapsules safeguard sensitive drugs from environmental factors like moisture, heat, and pH variations, thereby enhancing drug stability and shelf life. Moreover, microencapsulation allows for the modification of drug release profiles, enabling sustained or targeted delivery which improves therapeutic outcomes and patient adherence. Microencapsulation experts work on a range of formulations including oral, injectable, and topical systems, tailoring each to meet specific clinical needs and regulatory standards.
Microencapsulation experts also focus on process optimization, scalability, and quality control to ensure consistent production of microcapsules. They evaluate encapsulation efficiency, release kinetics, and biocompatibility through rigorous in vitro and in vivo testing. Their interdisciplinary collaborations with chemists, engineers, and clinicians foster innovation in encapsulating biologics like vaccines, enzymes, and probiotics. Through these efforts, microencapsulation experts play a crucial role in advancing pharmaceutics by creating safer, more effective, and patient-friendly drug delivery systems. Their work continues to drive the development of next-generation therapeutics that address complex medical challenges and improve overall healthcare outcomes.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia